HHV-8 Genetic Diversification and Its Impact on Severe Clinical Presentation of Associated Diseases
- 15 October 2020
- journal article
- editorial
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 222 (8), 1250-1253
- https://doi.org/10.1093/infdis/jiaa182
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Human herpesvirus type 8 variants circulating in Europe, Africa and North America in classic, endemic and epidemic Kaposi's sarcoma lesions during pre-AIDS and AIDS eraVirology, 2010
- Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Upregulates Survivin Expression in KSHV-Associated B-Lymphoma Cells and Contributes to Their ProliferationJournal of Virology, 2009
- HHV8 a subtype is associated with rapidly evolving classic Kaposi's sarcomaJournal of Medical Virology, 2008
- Kaposi's Sarcoma–Associated Herpesvirus Confers a Survival Advantage to Endothelial CellsCancer Research, 2008
- The malignant potential of HIV-associated Kaposi sarcomaCancer Cell International, 2008
- Intracellular Tat of Human Immunodeficiency Virus Type 1 Activates Lytic Cycle Replication of Kaposi's Sarcoma-Associated Herpesvirus: Role of JAK/STAT SignalingJournal of Virology, 2007
- Molecular epidemiology of Kaposi's sarcoma herpesvirus (KSHV) in Cuban and German patients with Kaposi's sarcoma (KS) and asymptomatic sexual contactsVirology, 2005
- Human Herpesvirus 8 in Brazilian Amerindians: A Hyperendemic Population with a New SubtypeThe Journal of Infectious Diseases, 2000
- Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcomaNature, 1994
- Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patientsNature, 1990